Today we have fantastic news to share – Medtronic has received FDA approval of the world’s first hybrid closed loop system! The MiniMed® 670G system is the most advanced insulin pump and sensor system designed to help people with type 1 diabetes spend less time worrying about their glucose levels and more time living their lives.

We know that people with diabetes can live amazing lives and achieve incredible things – you show us that every day! But we also know it takes an incredible amount of work to get and keep those glucose numbers in range. Our vision is to transform diabetes care together, for greater freedom and better health. Part of that means helping you spend more time in range so that instead of worrying so much about your diabetes, you can feel your best and focus on running that marathon, walking across that graduation stage, or just hanging out with friends and family on the beach.

There’s still more to do as we continue our work toward even more advanced solutions like a fully closed loop system. But the MiniMed 670G system is a big step toward that vision and we couldn’t be more thrilled to bring it to you.

SmartGuard™ HCL Technology. Less Worry. More Time in Range.

With our exclusive SmartGuard HCL technology, MiniMed 670G is a hybrid closed loop system. But what does that mean and how does it work? Well, when in Auto Mode, the pump automatically adjusts the delivery of your basal insulin (all that insulin your body needs when you’re not bolusing for food) based on our new, most advanced Guardian® Sensor 3. Auto Mode uses a target of 120 mg/dL and you do still have to enter carbs when you eat and enter blood glucose (BG) readings to calibrate the sensor– that’s why it’s called a hybrid closed loop system. But by automating that basal insulin, the MiniMed 670G system is requiring a lot less input from you than previous pumps and sensors.

Our New Guardian Sensor 3. Trusted to Power a Hybrid Closed Loop System.

The MiniMed 670G system includes our newest and most advanced CGM, the Guardian Sensor 3 and the Guardian Link 3 transmitter. In addition to enhanced accuracy and performance and a 7-day life, the Guardian Sensor 3 incorporates diagnostic technology that continuously monitors how the sensor is doing, resulting in a CGM system trusted to power the hybrid closed loop system. It’s the only sensor approved to drive the amount of insulin delivered by a pump.

We Hear You. You Need Options.

If there’s one thing that you’ve taught us, it’s that you like options! So if you’re not quite ready for Auto Mode available in SmartGuard HCL technology (and you probably won’t be if you’re first starting out on a pump and sensor), the system has two additional versions of SmartGuard technology available to you:

The Suspend on low feature (also available in the MiniMed 530G and MiniMed 630G systems) stops insulin delivery for up to two hours when the CGM sensor reaches a preset low.

The Suspend before low feature stops insulin delivery when the sensor is predicted to reach a low limit and resumes after sensor glucose levels recover.

A Spring 2017 Arrival.

While we’ve been working closely with the FDA on this product submission for the last several months, the approval did come much earlier than expected. Given this and the novel nature of the technology, we won’t be ready to ship the MiniMed 670G system until spring of 2017. In the meantime, we’ll be taking on important work such as getting our manufacturing lines ready, working with payers to secure reimbursement, and training our employees, physicians and diabetes educators on the new system to bring you the best possible onboarding experience.

Get On the Fast Track.

If you want to be first in line to receive the new system, check out the Priority Access program. Anyone who purchases a MiniMed 630G system between August 11, 2016 and when we ship the MiniMed 670G system will be eligible to upgrade to the new system for $299. In addition, if you want to take advantage of your end-of-year insurance benefits, you can buy your MiniMed 630G system between now and December 31st and pay $0 to upgrade, provided you participate in an approved System Access program. (Restrictions may apply.)

This is a great way for you to get used to our new pump platform via the MiniMed 630G system and be first in line once we’re able to ship the new system. You can find out more about the program here www.medtronicdiabetes.com/products/priority-access.

The MiniMed Family

The MiniMed 670G system is approved for people with type 1 diabetes, age 14 and older. Built on the same pump platform as the recently launched MiniMed 630G system, it also comes in our latest pump design with more customizable options and convenient features like a waterproof design and a color screen.

The MiniMed 670G system is the latest addition to a family of advanced diabetes management products. We’ll continue to offer other systems such as the MiniMed 630G system and the MiniMed 530G system with the MiniMed® Connect mobile app, which allows you and your loved ones to see your pump and CGM information right on your phone.

IMPORTANT SAFETY INFORMATION

The Medtronic MiniMed 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of Type 1 diabetes mellitus in persons, fourteen years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 670G System includes SmartGuard HCL technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values, and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed 670G System consists of the following devices: MiniMed 670G insulin pump, the Guardian Link (3) transmitter, the Guardian Sensor (3), One-Press Serter, and the Contour NEXT Link 2.4 glucose meter. The system requires a prescription.

The Guardian Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a home blood glucose monitor and not on values provided by the Guardian Sensor (3).

IMPORTANT: Medtronic performed an evaluation of the 670G close loop system and determined that it may not be safe for use in children under the age of 7 because of the way that the system is designed and the daily insulin requirements. Therefore, this device should not be used in anyone under the age of 7 years old. This device should also not be used in patient who require less than a total daily insulin does of 8 units per day because the device requires a minimum of 8 units per day to operate safely.

The MiniMed 670G system is not approved for use in pregnant women and patients with impaired kidney function. For complete warnings, precautions, and contraindications, please consult the User Guide.

About Author

Karrie Hawbaker is the Senior Manager, Social Media for the Diabetes Group of Medtronic.
She joined Medtronic in January 2011, after a decade of experience working for health, science and technology organizations, she jumped at the opportunity to use her skills to help Medtronic improve the lives of people with diabetes and has never looked back. Since then, she is continuously impressed and inspired by the passion, kindness and warmth of the diabetes online community.

Latest Comments

Luke Schmidt

Is there any way to get on the priority list if you are currently using a MiniMed® 530G with Enlite®?

I am a little confused by this reply by Karrie. I have the 530 currently and was just planning to upgrade to 630 when my warranty ends at the beginning of November 2016. Of course I am now interested in the newest 670 and reading this http://www.medtronicdiabetes.com/products/priority-access, it seems that if I do proceed to get the 630 as planned before the end of this year, I will then be able to 1) get priority access when the 670 does become available next year and 2) not pay anything additional out of pocket as per footnote **.

Hi Dessi – that is correct, if you purchase the MiniMed 630G system in November, you’ll be one of the first in line to get the opportunity to upgrade to the new system for a low cost, or possibly no cost.

I just received a new pump in June just before the 630G was available. I’m positive I cannot get another upgrade before the end of the year, and I’m a little upset that a rep. didn’t tell me about the 630G when I ordered another 530G. 🙁 I’d love to have first access to the 670G. Any way this can happen for those of us with Enlite and the 530?

October 13, 2016

Karrie Hawbaker

Hi Staci – we have a variety of different programs that will help many customers upgrade to the MiniMed 630G system. They vary by insurance coverage, time since you bought your last pump etc. We’ll share more information in November so check back in with us then.

I have a pump that says it’s a 751NAB with an enlite system. I love it and it’s been able to keep me from having those low glucose events late at night when I’m sound asleep. Is it possible for me to get into one of these new systems? I’m a type II diabetic and would love to give this new system a try. Will this be possible?

October 14, 2016

Karrie Hawbaker

Hi Robert – The MiniMed 670G system is not approved for people with type 2 diabetes. We encourage you to discuss your options with your healthcare team.

October 17, 2016

gerard gaillard

I guess if you have a 530g you have to wait i guess thats how medtronic works older devices have to wait newer devices get a guicker upgrade .WOW

I am asking for my daughter who has T1D and has just been approved by her plan for the 670G but not the sensor unless she adds a DME to her existing insurance at a very costly monthly charge. Is there anything she can do or any organization that can help her avoid this charge ?

Hi Jennifer – MiniMed Connect uses a different radio frequency (RF) to communicate with MiniMed 530G (and MiniMed Paradigm Revel) than the RF frequency that the MiniMed 630G pump and MiniMed 670G pump uses. For customers interested in the connectivity benefits of MiniMed Connect and its remote monitoring features, we recommend the MiniMed 530G system.

I really, really hope that Medtronic will update Connect/Carelink or design a new monitoring system compatible with the 670G. After being able to see my son’s numbers while he’s at school, field trips, play dates, etc…..I don’t think I can ever go back to operating “blind”. While the features of the 670G are soo exciting, not having a remote monitoring system might be a deal breaker for our family.

Yes , we need connect for our children! Please get it for the 630 and 670! Thank you

December 6, 2016

deb

This system would be more awesome of you could make it all in one!! Too many holes and not enough real estate. My husband has the system but only uses the pump. It has been a lifesaver but until they are combined he won’t poke 2 holes.

Same here… the pump is great but the sensor pin is ridiculously long that it wont penetrate my muscle. At 175 pounds, 7% bodyfat (weithlifter) I can’t get the pin to penetrate the muscle. It just hits and stops, and FORCING it in manually is not an option if you’ve not tried it. So, until you come up with something better….

Hi David – the FDA did not include people living with type 2 diabetes in the labeling for the MiniMed 670G system. We will conduct ongoing studies to expand the indication to additional patient populations. In the meantime, we recommend that you speak with your healthcare team about the best therapy options for you.

Hi Lilly – You will need to calibrate the Guardian Sensor 3 every 12 hours, the same as with our current systems. The MiniMed 670G system is the world’s first hybrid closed loop system and our latest step toward a fully automated closed loop system. It includes our most advanced version of our SmartGuard HCL technology

Is there an upgrade program for 530g users to upgrade to the 630G, so then we can take advantage of the priority access program for the 670G? (I am not eligible to upgrade through my insurance for another two years). I want to ensure I can get a 670G right away!

Will the 670 system be compatible with the Minimed Connect Mobile App? We would like to still be able to view my daughter’s blood sugars on our phone, but I can’t tell if this feature will be an option with the new system? Thanks

Hi Shannon – MiniMed Connect uses a different radio frequency (RF) to communicate with MiniMed 530G (and MiniMed Paradigm Revel) than the RF frequency that the MiniMed 630G pump and MiniMed 670G pump uses. If you want to continue to see your daughter’s blood sugars, we recommend the MiniMed 530G system.

Hi John – customers who order the MiniMed 630G system will automatically be on the list to upgrade once the MiniMed 670G system is available. We will make sure to announce to our community once the new system can be ordered and you can give us a call to place the order.

I think for being a part of the Medtronic family in general we should be granted Priority Access for this new device. I just upgraded my pump a few months ago so it’s doubtful my insurance would approve another upgrade for the 630 just so I could be notified and get special pricing when the 670 comes out.

Hi Anna – if you’d like to discuss your options for upgrading to the MiniMed 630G system, please send us an email with your contact information to dhelp@medtronicdiabetes.com and a member of our team will reach out to you.

I agree with Anna, I just upgraded to a 530G this summer. The 630G was released soon after. My insurance only covers a new pump when it is out of warranty so I’m now on old technology for another 4 years. It is too bad those recently upgrading to any model pump are not offered a Pathway program for the 670G instead of just the 630G users. I’ve been on a pump for 16 years and this has happened for the 2 upgrades.

Hi C – I’d like to have someone follow-up with you to see what your upgrade options are. I will have someone from my team reach out to you. Please know that our focus has been on making the hybrid closed loop system available as quickly as possible and we saw an opportunity to expand our product portfolio while bringing this system to market. It is often difficult to predict regulatory timelines and the speed at which the FDA-approved our submission was unprecedented and unexpected.

I am a current 530g user for a little over 1 year with tremendous results an A1c of 6.4 just checked yesterdayI have had nothing but good results and service with Medtronics since I started with insulin pump therapy back in 2000, why would you take the newer pump users first, I find that quite frustrating being stuck with old technology for another 3 years until the warranty is up Thank you for your attention to this matter and for the quality of life Medtronics insulin pumps have offered me

Hi Tom – So glad to hear that the MiniMed 530G is working well for you. Congratulations on your A1c. Through Priority Access customers who are on the MiniMed 630G system will be first in line to receive the MiniMed 670G system. This allows those users to get familiar with the new platform before upgrading to the hybrid-closed loop system. If you’re interested in your options to upgrade to the MiniMed 630G system, please email us at dhelp@medtronic.com.

I’ve been type 1 for 41 years now and still waiting for non-intrusive testing and/or electronic measuring devices that are accurate. If I still have to poke finger multiple times a day to verify the sensor then it’s not going me any good and now tieing me down to 2 devices instead of one. I DAW the future of non intrusive testing on the early 80’s only it never came to market. Still waiting on that. Then you will have s device to live for.

Hi Joni – we cannot discuss the use of this product for women who are pregnant. We do not have clinical data to support use of the MiniMed 670G system with women who are pregnant at this time. We encourage you to discuss your options with your healthcare team.

Hi Cassidy – there is a slight increase in size from the MiniMed 530G system. The main reason for the increase in size is to accommodate the AA battery which is required to properly power the pump and color screen. The infusion sets for both the MiniMed 670G system and the MiniMed 530G system are the same.

I would love for MiniMed to make a wireless pump…I have one and if the whole closed loop system could be put into a wireless system I would buy it in a heartbeat. Out of pocket too. Also be great if it was wireless if the smartphone could control the pump. Things to look forward to in the future I suppose. But this is a step in the right direction and may switch to not have to worry so much about low blood glucose as I always tend to run on the low end

I see that the “target range” is 120. This past year, after 40 years of T1, I started a low carb diet. Currently, my target is for normal BG of 84 ( with 65 and 110 my parameters). Is this target of 120 adjustable? I’m very excited about this system because fine tuning Basal is one of the primary keys to success with T1 although most medical personal and patients don’t realize this. However, if the target is not adjustable, then it would be of little use to diabetics striving for normal BG and A1Cs. Thanks for your answer in advance.

Hi Colleen – thanks for asking. I’m glad you found something that works well for you. The target is 120 mg/dL and is not adjustable. We designed the system this way in the interest of getting the product to market more quickly (having multiple options would have added a lot of time and complexity to the clinical trial).

Similar to Colleen my BG target is 85 and my high and low alarms are set to 110 and 65 with my threshold suspend at 60. The hard-wired target of 120 is disappointing. Does that mean that if I use auto mode on the 670G my A1c is most likely to rise?

Hi Barbara – we do realize that each individual has their own target blood glucose. We can’t speak to details specific to your individual situation and recommend that you discuss this with your healthcare team. Keep in mind that you can also use the Suspend on low feature which is adjustable and you will be able to set your own low thresholds.

It’s really off putting and disappointing that Medtronics chose to rush instead of creating a clincial trial that could allow people to chose their own target range…
Why is rushing the pump top priority? Medtronics should take time and patience when creating a pump that human beings use.
Medtronics is great – but that is disappointing.

October 25, 2016

Jeff Donovan

When do you anticipate my 10 year old being able to get 670G? We are in the market now for a pump. If we go with the 630G will we be able to upgrade when approved? Thank you!

Hi Jeff – the MiniMed 630G system is only approved for those who are 16 years and older. The MiniMed 670G system is approved for those who are 14 years and older. We recommend reaching out to your healthcare provider for the best options for your child.

Great advancements. I’ve been T1D 41 years and my only objection to the 670G is that the user not having the ability to set their own target. I’m a brittle T1D and can experience very rapid changes in my blood sugar level. I test 30 times daily, down from 50 due to my insurance carrier. 140 is my target and works quite well for me. I wish that Medtronic had truly thought about that on the patient level, trust me it would prompt me, and probably Mike who commented above, as well as thousands of other pump users.

Thank you for this exciting news as the next great step forward in combating this terrible disease. If you are able to comment, are there plans for clinical trials in preteen patients? Growth spurts commonly occur in this age group and can make achieving stable blood sugars challenging. The potentially life saving low safety features (which I realize are available on other Medtronic devices) coupled with the new basal algorithms seem ideal for this populations of Type one heroes.

I have had Type 1 for 38 yrs. I already had a pancreas transplant that lasted 6yrs and failed. I am back on Paradigm Real-Time Revel MiniMed Pump & Enlite Sensors & Contour Next Link Blood Monitoring System. I am an unusual Type 1. I have Low blood sugars & go unconscious frequently which is why I had the transplant initially. The pump system I have now isn’t helping me so I know my MD would definitely put in for a medical necessity. I am now living alone and would obviously like to stay alive. I check my blood sugars at least thirty times a day as it is for safety now and even with my pump down it’s still extremely difficult. Is there any hope?

Hi Jeannine – there are a number of factors including your doctor’s prescription, insurance coverage and warranty on your current pump. If you’re interested in learning more, I recommend giving us a call at 800-238-7111.

Have you ever considered a Diabetic Service Dog? My daughter first heard about them and I just got a puppy with the hope of having him trained. The will alert you to when your sugar drops. Just a thought!

My daughter was actually waiting for the upgrade. Since ship date isnt for 2 months & we have not even been contacted for our information. Will we now have the option to pass on the 630G & wait the few more months for the 670G? Rather than having the hastle of learning 2 systems?
Thanks

Hi Danielle – those who move forward with the MiniMed 630G system will be first in line to get the MiniMed 670G system in spring 2017. If your daughter is eligible for an upgrade now, you might want to look into the MiniMed 630G system. This will also allow you to get up to speed with this latest platform of insulin pump therapy.

Hi Jami – no, MiniMed Connect uses a different radio frequency (RF) to communicate with MiniMed 530G (and MiniMed Paradigm Revel) than the RF frequency that the MiniMed 630G pump and MiniMed 670G pump uses. For customers interested in the connectivity benefits of MiniMed Connect and its remote monitoring features, we recommend the MiniMed 530G system.

Congratulations, these are great news. I believe that this decision came much ealrier than antecipated.

I live in Portugal and I have (actually, i is my daughter) the Minimed 640G (which is the same as the 630G in the US). What are your plans regarding Europe, in general, and Portugal in particular? When do you think I will be able to buy this pump in Portugal. do you think that 2018 is feasible, or am I being overly optimistic?

I received my 530G this past February 2016. Do I understand correctly that there may be a possibility for 530G users to upgrade to the 630G later this year? And then upgrade to the 670G when it’s released in 2017? I don’t know if my insurance company will approve another pump; I’m certain there are other customers in the same situation. How can I find out about the upgrade options for 530G users? Thanks!! Keith

Hi Keith – you are correct. We will have upgrade options in November for those on the MiniMed 530G system to upgrade to the MiniMed 630G system. From there you will be able to take part in the Priority Access program to get the MiniMed 670G system. We will make sure to keep our community updated on the options to upgrade.

This is very exiting to me. Congrats to everyone at Medtronic for all the work on making this happen. Lots of cool things about this, and I am very interested in seeing how the new Guardian 3 compares once it’s being used out in the real world. Yet, the lack of data-sharing and not being able to change the 120 target are two big negatives for me. Those two things alone could very well make me look elsewhere or wait for whatever’s next. Anyhow, great job on this and I look forward to seeing it all materialize with the product launch.

Will Medtronic come out with a data sharing mechanism for this system?
It is very frustrating that the MySentry quickly became unusable once the 530 G came out.
Yes, many of us want data sharing AND the new elements available in this hybrid system.

Hi Leslie – both the MiniMed Connect app and mySentry reside on incompatible radio frequencies from the MiniMed 670G system. We are committed to providing these types of solutions to customers and exploring viable alternatives.

I’m very happy to see some advancements for type 1’s. Admittedly, I have not kept up with many of the newer advancements in decades. I declined to attempt to use the insulin pumps when they first came out. I had tried a few variations in decades past, such as Lantus, but my body did not fair well on it, so I reverted back to my proven method, mixing R&N insulin’s, which I am on Novolin now. I am now researching this new technique after seeing the news report released. I am very curious of why only 123 participants were done in this study? I would have thought many more participants would have been required. But, I was also amazed to find that type 1’s are only 5% of the diabetic population. I was diagnosed type 1 on March 29, 1979. By the time this will be released in the Spring of 2017, I will have taken almost 30,000 insulin shots. After having major back surgery in November of 2013, my condition of my diabetes has taken a hard turn. My major complication is with neuropathy and the meds for that is greatly interfering with my ability for my body to let me know if my sugar is high or low now. This new system will hopefully be the new answer to resolve my new condition and issues. I am hoping it will help to greatly regulate changing sugar fluctuations, which I can no longer feel taking place in my body, as I ha relied heavily on in past decades and what has allowed me to still be functional, with my blood sugars still being within reasonable ranges. Does the company expect to have any more trials, specifically regarding very long term type 1’s such as myself? Thanks in advance.

Hi Steve – thanks for reaching out. If you’re interested in being part of clinical trials, please visit clinicaltrials.gov to find more information and add “Medtronic Diabetes” in the search bar if you’re interested in our technology.

Hi Barbara – When in Auto Mode, the MiniMed 670G system automatically adjusts basal insulin delivery based on sensor glucose values and recent insulin delivery needs. Auto Mode uses a target of 120 mg/dL and requires you to enter carbs when you eat and enter blood glucose (BG) readings to calibrate the sensor.

Hi Mike – the Priority Access program is for customers who would like to go on the MiniMed 630G system first. Since the question asked the specific price for the MiniMed 670G system, we don’t have that information available until the system is commercially available. We do anticipate it to be available at currently offered Medtronic pump system pricing.

Hi Mary – Now that we have FDA approval, we’ll be partnering with payers to drive broad access for this new technology. More information will be shared when the MiniMed 670G system is available this spring.

When there is only one attachment to the body OR you can read glucose another way (I know you are working on that) then you will have something. Having to have 2 punctures to the skin does not work. Do you realize for someone who has used a pump for 30 years how much damage to the skin DOUBLE that does? Sure its less than several needles a day, but you can do much better.

It is sad to me that priority for the 670G is only being given for those who already have a 630G. My son doesn’t qualify for the 630G because he is only 15 & the approval for the 630G is for 16 years and older. Wouldn’t it make more sense to allow all loyal Medtronic customers to get on that “priority” list rather than excluding some because they don’t qualify due to their age? 🙁

Hi Lyn – I’m sorry that you are disappointed. Your son will have access to the MiniMed 670G system, since it is approved for people with type 1 diabetes ages 14 and up and we will have upgrade programs available in the spring once the MiniMed 670G system becomes commercially available. Each time we introduce something new, we do our best to put together programs to help our current customers access the newest technology.

I completely agree – “too many holes & not enough real estate” is often the case for many of us long time Type 1’s. Please develop an implantable glucose sensor that will interact with a pump so that we can stop poking so many holes in our bodies. Thanks!

Any news on the connect app for Android. Been waiting months since the is version was released.

The 670 is on one hand a nice step forward but to lose the connectivity that is in place for some users and to tie it to a single target is disappointing. Last issue I want to comment on is that those with high frequency hearing loss have a hard time hearing the alarm. It would be helpful if the frequency of the alarm could be adjusted!

Hi Dave – we should have an update on the MiniMed Connect app for Android soon. We will make sure to update our community once available. Also, on the MiniMed 670G system you will have the ability to customize alerts so that they can be changed throughout the day based on individual needs, and alarms with loud and discreet options (volume ranges from vibrate only to twice as loud as previous Medtronic insulin delivery systems).

All components within the MiniMed 670G system communicate on the 2.4GHz frequency, a globally-recognized radio frequency (RF). This frequency was chosen to increase the reliability and wireless range between the pump and connecting devices as compared to previous Medtronic systems.

Regarding the 120 mg/dl target range; I want to see if I understand this correctly. The pump will maintain a 120 mg/dl target by adjusting the basal rate; so if your blood glucose rises to say 150, it will adjust the basal insulin to bring it back into the 120 range – correct?

I am 44 plus years type 1. Still active playing basketball 2-3 days a week year round. How has the adhesive issues improved over the years? I was on a CGM system for less than 2 weeks because I could not keep the sensor in long enough and recalibrating every 2-3 days was a huge inconvenience. Not to mention a PITA. So I went back to testing 8-10 daily and wearing a pump which I love. Any thoughts on that?

I have been type one for 60 yrs. Because of the length of time my complications have made it impossible to sense low blood sugars. At this time I am using mini meds 520. Am checking my sugar levels with a meter and test strips at no cost. My insurance changed Jan 1 last yr my old ins paid for the entire monitor but June of last year and a new pump. I was notified by the company due to an error in billing I was gong to have to pay for the enlite sensor myself. I quit using the enlite product because of the cost. In two months I will be out of debt with mini Med and will start using enlite sensors. It’s my understanding Medicare does not cover the cost of the enlite sensor because it s a new product. I have diabetic unawareness and can’t tell f my shar is up or down. I currently test 10 times daily. Is there a date set for Medicare to cover the sensors? If so when might I get help wth insurance paying some of my cost. Thanks for listening Sam

Hi Samuel – Medicare currently does not cover for CGM, though Medtronic is actively working with the Centers for Medicare & Medicaid Services (CMS) to ultimately establish coverage consistent with other healthcare insurance companies in the US. If you would like to learn how you can make a difference, read our blog on the Medicare CGM Access Act http://bit.ly/1LvQHlG.

Great that I can use the infusion sets and reservoirs that I already have stocked up. What about sensors? Will the Enlite sensors work with a new transmitter, or will we switch to all new CGM components?

Hi Tom – now that we have FDA approval, we’ll be partnering with payers to drive broad access for this new technology. More information will be shared when the MiniMed 670G system is available this spring.

Hi Nina – if you received your MiniMed 530G system last year, you are likely still in-warranty. We’ll share more information in November in regard to the different programs that will be available to help customers upgrade to the MiniMed 630G system.

Hi Beverly – We have a variety of different programs that will help many customers upgrade to the MiniMed 630G system. They vary by insurance coverage, time since you bought your last pump etc. If you’re interested in finding out more, please feel free to check out our Priority Access page here: http://www.medtronicdiabetes.com/products/priority-access.

I just reordered $500 worth of pump supplies (infusion sets and reservoirs) for my Paradigm. The day I got the supplies, the pump broke. So now I am on a loaner and shopping for a new pump. Will these supplies work with the 630G and then the 670G if I go this route? Or should I try to return all the extra supplies?

Hi Barbara – the same infusion sets will work with both the MiniMed 630G and MiniMed 670G systems. The reservoirs for the insulin pump will take the 3mL reservoirs if that is what you are currently using.

Hi Karrie, so the infusion sets and reservoirs from the 530G will work with the 630g and ultimately the 670G, correct? But the Enlite sensors are different; I need to order new CGM sensors soon but I’m hesitant to buy them for my 530G if the Pathways program will begin in November. Any suggestions?

Hi Ron – that’s correct on the infusion sets and reservoirs, but keep in mind that it is the 3mL reservoirs for the new platform. As for the sensors, the MiniMed 630G system is approved with the same Enlite sensors you are currently using, however the MiniMed 670G system will use the new Guardian Sensor 3. Those will be available in early spring once the MiniMed 670G insulin pump is also available.

Hi Jack – We have a variety of different programs that will help many customers upgrade to the MiniMed 630G system. They vary by insurance coverage, time since you bought your last pump etc. We’ll share more information in November so check back in with us then.

Hi Mike – that is correct there are two insertion sites. The first one is for the infusion set which needs to be changed every 2-3 days and the second is for the sensor which needs to be changed every 6 days. The size of the transmitter which attaches to the sensor is the size of a quarter.

Will the new CGM sensors mentioned in the 670G announcement also work with the 530G pump? If so, are they equally advantageous when used with the 530G? (Sorry for the jargon, but it seems from your blog that your customers understand it.)

Thanks for reaching out Ron. The Guardian Sensor 3 which are the sensors that are approved for the MiniMed 670G system are only approved for that system. For the MiniMed 530G system, the approved sensor is the Enlite sensor.

Hi, just wanted to share my input.. I tried the sensor before but found it a lot inaccurate.
When I was giving alarms for
Lows or highs actually checking on my blood sugar levels it was either the opposite or off by >40 points either direction which is why I decided to stop using it.
I have been on the pump for more
Then 10 years now and I love it. It seems that the sensor technology has improved so much that actually I will loke to try it again.
Is it possible for you guys to create an inline attachment (sensor) with the actual infusion set so we dont have to stick/ add another device on our skin??
Thanks
Andrea

How reliable is the sensor? I have the 530/Enlite and the sensor was losing connection with the pump several times a day and I had to replace the sensor several times each day. After a couple of weeks of this and consulting with a Minimed rep, the issue remained, so I simply gave up on using the sensors.

Hi Karlie,
How does the Guardian 3 sensor compare to the Enlite in terms of the materials used to make it? Like others have brought up, I don’t have many options for where I can insert infusion sets and sensors; the only places available to me are around my abdomen, meaning my waistline. The Enlite sensor is too fragile to withstand all the bending, so I can’t wear it. Would I have the same problem with the Guardian 3?

Do you know the reasoning behind this? Is this a permanent decision to not produce any pumps with the lower capacity reservoirs? If I use the larger reservoir, I will be throwing away a great deal of insulin if I change every three days as recommended. What are the people like me suppose to do going forward?

Is the same deficient attachment tape set up used on the Sensor 3 as the one used on the Sensor 2? That tape is not sufficient for a person who sweats in the summer during anything like yard work or athletic activity. I’ve had several sensors come off early due to this and have tried all the taping suggestions on the website and all the other tapes (tegaderm, etc.) suggested. The insulin infusion site tends to do well even though it seems to be the same type tape due, perhaps, to the extra tape surrounding the site or the lighter weight of the apparatus. I wouldn’t dare switch to something more expensive and intended to last a day longer without some major improvement in the attachment tape.

Hi Larry – there have been minor modifications that could change your experience. I suggest reaching out to us once the new Guardian Sensor 3 is available to see if viewing the new transmitter and adhesive in person is possible.

Hi Darry, we’ll be partnering with payers to drive broad access for this new technology, now that we have FDA approval. We will share more information once the MiniMed 670G system is available this spring.

I currently use the Paradigm Real-Time Revel (MMT-723NAS). I’ve been on a Minimed pump since 2001 and absolutely love it. I’ve had this one since 3/2010 and am very used to it. I have used the sensor some but (1) the sensors are very expensive with my BC/BS insurance and (2) I have to secure the transmitter/sensor with an IV sheet I get from you. I am not allergic to anything but those sheets do cause an irritation. Is that how the new 670G sensor would have to attach? I check glucose (sticks) 10 times a day average and do not mind poking holes in myself at all and the 7 day use would be fabulous too. I’ll speak to my rep about the best way to do an upgrade. It would just make too much sense for insurance to cover more of the pump supplies. Keeping me healthy preventatively and encourage complete pump and sensor use would be less output on them in the long run. But then, no one asked me.

Hi I currently have the 530 but my warranty I believe does not end until feb 2017. I know my insurance would pay for it since it’s considered an upgrade but I was told by one of your operators that I could not do it that way. He mentioned a way to upgrade through a pathway 2 program? Can you tell me what I would need to do to get the latest model which is the one in the spring.

Hi Rosa – we will have a variety of different programs that will help many customers upgrade to the MiniMed 630G system and then to the MiniMed 670G system. Depending on when your warranty ends, you may want to wait to upgrade until the MiniMed 670G system is available in the spring. We’ll share more information in November so check back in with us then.

Hi. I currently have a 751 Paradigm insulin pump that I use with the enlite CGM. Is there any sort of discount offered for a little bit, but not a whole lot, older pump? This is amazing technology but got a new pump last year and there is no way my insurance company will cover a new pump. And feedback would be appreciated

Hi Alex – we have a variety of different programs that will help many customers upgrade to the MiniMed 630G system. This does vary depending on insurance coverage, time since you bought your last pump, etc. We will be sharing more information in November, so please check back with us then.

Hi Rick, now that we have FDA approval, we’ll be partnering with payers to drive broad access for this new technology. More information will be shared when the MiniMed 670G system is available this spring.

I have used the Minimed Pump for over 17 years and the CGM since it came out from the beginning. My 530 pump warranty expires December 31, 2016. I was told it would probably be best for me to wait and get the 670 . My question is I want it when it becomes available with insurance coverage and a warranty. I have been a loyal customer for over 17 years and now you are saying the only way to be one of the first is to get the 630 and I will be able to upgrade to the 670 first. Customer loyalty doesn’t count for anything.

Hi Jennifer – the MiniMed 670G system will be available in spring 2017. If you’re interested in upgrading to the MiniMed 630G system once your warranty expires, we will be able to include you in the Priority Access program.

Hi Jennifer – now that we have FDA approval, we’ll be partnering with payers to drive broad access for this new technology. More information will be shared when the MiniMed 670G system is available this spring. We also do have financial assistance available for those who qualify.

Hello Adalea – We have a variety of different programs that will help many customers upgrade to the MiniMed 630G system. They vary by insurance coverage, time since you bought your last pump etc. We’ll share more information in November so check back in with us then.

Hello Sinead – In order to qualify for the Priority Access program you do need to be using the MiniMed 630G system. If you’re using a Paradigm pump, there will be upgrade options available which will be announced once the product is commercially available next spring.

My only problem with being a Type 11 diabetic on a pump is the contriction of a 25 unit bolus limit. This means you have to do a second bolus for anything over 25 units. In Europe the bolus limt is 75 units. It appears the new 630G is also capped at 25 units. Can you explain why this hasn’t been addressed?

Hi Richard – the max bolus feature provides a safety measure by limiting the total amount of bolus insulin you can program for a single bolus delivery. This makes it so you do not accidentally take too much insulin at one time.

We have a 630G and are excited about the 670G. With the in range goal being 120 will it automaticly bring you up to 120 if you are say 90 and not low? We usually have a good A1C in the high 5% to low 6% range and I’m concerned without adjustable parameters it will go up.

Hello- just wanted to add my two cents worth! I have the new 630 G model and I am disappointed that the pumps seem to be getting more cumbersome and larger. I am not interested in all the bells and whistles, I do not care if the display is colored. I want something small that fits into my pocket or waistband without getting caught on things. I’m a nurse and have gotten my pump caught while working. My paradigm model took 2-3 pushes of a button to bolus and this new model takes many more. Things should be getting more streamlined in my opinion. Also my previous pump was clear and I could hide it in my clothing (bra) easily. Now the pump is black and too big ☹️ Will Medtronic be offering smaller versions soon? My 1st pump 16yrs ago was tiny in comparison. I’m considering going back to injections.

I agree 100% with Carri. Why would Medtronic market a device that is larger? I find that very perplexing. I currently use the 530g and I’m very hesitant to upgrade. Sure I would love to have the “bells and whistles” but in my opinion I think Medtronic made a big mistake not making the device the same size as the 530g. The other thing that blows my mind is that they did not make the device blu-tooth enabled so that readings can be sent directly to the users smartphone. I know that I am not the only one that feels this way based on previous posts. Someone needs to be relaying this information to R&D. I guess that would be you Karrie , right?:)

Hi Chris – thank you for the feedback. I will share with our team. Please know that the increase in size over Paradigm is to accommodate the AA battery which is required to properly power the pump and color screen.

Hi Ricky – you’ve already taken the first step by going on the MiniMed 630G system. Once we have more information available on next steps for the Priority Access program we will make sure to let our community know.

Hi Christina – no the target of 120 mg/dL is not adjustable and the MiniMed Connect uses a different radio frequency (RF) to communicate with MiniMed 530G (and MiniMed Paradigm Revel) than the RF frequency that the MiniMed 630G pump and MiniMed 670G pump uses. For customers interested in the connectivity benefits of MiniMed Connect and its remote monitoring features, we recommend the MiniMed 530G system.

I apologize if this question has already been addressed above. I am really interested in the 670g. However, I am also a marathon runner. Immediately before I run, I intentionally spike my blood glucose so I can go greater distances before supplementing sugars. Currently, I use the temp basal feature and it works amazingly well. Is there a way to suspend the auto-basal feature without suspending delivery entirely? Thanks!

Great question, Steve. Auto Mode uses a target of 120mg/dL but this can be increased temporarily to 150mg/dL. The Auto Mode feature automates basal insulin delivery based on your sensor glucose values and insulin delivery needs to keep you at the preferred range. However, if you need to turn off Auto Mode you can do so.

I have not heard anything about this new pump and would really like to look into this. I am a T1 diabetic and have been almost all my life. I never knew anything about insulin pumps but since I have been on the 530G pump it has saved my life more times then I can admit. I occasionally have lows and being by myself it does scare me and that’s why I stay on top of my change outs. I don’t have a problem with the double pokes because it is a life saver for me. I want to thank Medtronic for there efforts in continually making people with T1 diabetes live better.

I like the fact that it stops insulin delivery when a low point is reached or it calculates a low point will be reached. Does it restart the insulin delivery automatically when the low is no longer a factor or will I need to manually restart the insulin delivery?

Also, what about highs. Does the 670 increase the basil or give an extra bolus when a high value is reached automatically?

Is the value of the low and high a user adjustable value or is it pre-set within the pump, like the 120 target value?

1) The Suspend before low feature stops insulin delivery when the sensor is predicted to reach a low limit and resumes after sensor glucose levels recover.
2) When in Auto Mode, the pump automatically adjusts the delivery of your basal insulin (all that insulin your body needs when you’re not bolusing for food) based on our new, most advanced Guardian® Sensor 3. Auto Mode uses a target of 120 mg/dL and you do still have to enter carbs when you eat and enter blood glucose (BG) readings to calibrate the sensor– that’s why it’s called a hybrid closed loop system.
3) The MiniMed 670G provides three different levels of automation so you and your healthcare team can customize based on where you are in your diabetes journey: Suspend on Low (similar to what is in the MiniMed 530G and MiniMed 630G systems), Suspend Before low (similar to what is available in MiniMed systems outside the US) and Auto Mode, the world’s first hybrid closed loop technology. When in Auto Mode, the system is continuously adjusting the amount of basal insulin it is delivering in order to keep you as close to 120 mg/dL as possible. If you’re not in Auto Mode, you have the option to use the Suspend on Low or the Suspend Before Low features and those can you can set between 60 and 90 mg/dL.

Hi Jared, if you’d like to look into your warranty date, please give us a call at 800-646-4633, option 1. Typically warranties are 4 years in length but it does depend on your insurance. In the meantime, we encourage you to check out the Priority Access program available with the MiniMed 630G system. http://bit.ly/2dE9QHi

Hello Idit – At this time I don’t have a timeline for you in regard to the MiniMed 670G system. The summer of 2017 is also just a general guideline of when we anticipate the product to be available in other countries. We do have to follow local regulatory guidelines when introducing a new product. It is best to follow-up with your local Medtronic team for the best timeline.

Hi Karri,
Thanks for your answer.
I know I’m not making it any easier on you but I have recently visited my endrocrinologist and he mantioned the 690G .
He said that it will be in the market 5 years ahead from today.
Is that true?!

Sorry for my multiple questions – I can only have 1 pump every 6 years so it’s very important for me.

Hi Karrie,
Are these insulin pumps only for type 1 diabetes? If so, why? Is it possible to see any of the clinical trial data. I am aware that this is a class III device. Are there any devices compatible to patients with Type 2? Are these devices compatible with smartphones? If not, why? What is this device retailing at? Are there reimbursements?

Thanks for the questions Paul. The MiniMed 670G system is only approved by the FDA for those living with type 1 diabetes. Our clinical trial only included people living with type 1 diabetes. If you have additional questions, we do encourage you to discuss them with your healthcare team. Our other systems are FDA approved for those living with type 2 diabetes who require insulin and are 16 years of age or older. At this time, the MiniMed Revel or MiniMed 530G systems are compatible with MiniMed Connect which works with your smartphone. We do work with more than 600 insurers nationwide. If you’re interested in seeing what your out of pocket costs are for any of our systems, please give us a call at 800.646.4633, option 3.

Hi Karrie,
I have just received the 630G and I find that the CGM is much more accurate, and I have been happy with that. I have been on a pump for about 30 years and have always used the MiniMed pumps. I have had type one for 35 years, I do exercise regularly and I am doing quite well. My previous pump was the 530G, I use about 45 units of insulin per day. Will they be making a version of the 670G that will use the 1.8ml reservoirs? Using the smaller reservoirs allows me to keep them in 3 to 4 days.

Tracey, both the MiniMed 630G and MiniMed 670G systems are waterproof. At the time of manufacture, the pump is waterproof in up to 12 feet of water for 24 hours at a time. The Guardian Link transmitter is waterproof in up to 8 feet of water for up to 30 minutes.

I understand that the 670G is currently only FDA approved to work with the Contour NEXT Link 2.4 in the US. With the Medtronic partnership with Roche Diabetes Care and the announcement that Roche is developing its new Accu-Chek meters, such as the Accu-Chek Guide Link, to communicate with Medtronic insulin pumps, will the Accu-Chek meters be made compatible with the 670G? Or will this only affect future pumps after the 670G?

So you are saying that the 670G will only ever work with the CONTOUR NEXT LINK 2.4 and there are no plans for the 670G to work with any of the Accu-Chek meters being developed to communicate with the MiniMed pumps and that the Accu-Chek meters will only work with future MiniMed pumps that have not yet been released?

Kevin, we can’t speak to any future product availability but at this time, the MiniMed 670G is only integrated with the CONTOUR NEXT LINK meter. You can use the meter of your choice but will need to manually input your BG readings.

So at this time, all there is are the press releases and announcements from last year and earlier this year for the partnership between Roche Diabetes Care and MiniMed as well as the announcement of the development of the Accu-Chek Guide Link to specifically communicate with MiniMed pumps. And that the current Accu-Chek pump users that have been informed that from now on must order their Accu-Chek pump supplies from MiniMed or a 3rd party supplier.